Character Biosciences, a precision medicine company transforming drug development for polygenic diseases, announced an expansion of its Series B financing, bringing total capital raised in the round to more than $110 million. The additional close included participation from Sanofi Ventures, as well as new and existing investors..

字符生物科学公司是一家致力于改变多基因疾病药物开发的精准医疗公司，宣布其B轮融资扩大，使此轮融资筹集的总资本超过1.1亿美元。此次额外融资得到了赛诺菲风险投资公司以及新加入和现有投资者的参与。